A multi-state study published in The Lancet found the RSV vaccine to be highly effective in protecting older adults against severe disease, hospitalization, and death. The vaccine provided approximately 80% protection against these outcomes, including severe disease and ICU admission.
A new study found that COVID-19 infection increased the risk of heart attack and stroke for up to three years after infection. The risk was higher among people with A, B or AB blood types compared to type O, according to researchers analyzing data in the UK Biobank.
Researchers at La Jolla Institute for Immunology have developed six lines of humanized mice to study human cases of COVID-19, shedding light on SARS-CoV-2's movement through the body and varying symptoms. The models help understand how different genetic backgrounds influence disease progression.
Washington University School of Medicine researchers will study how vaccines trigger long-lasting immune responses, comparing them with effective lifelong immune responses. They aim to understand factors that enable enduring immunity after vaccination and inform the design of nasal vaccines for respiratory viruses.
A multinational study found that people with unmedicated mental illness are less likely to be vaccinated against COVID-19, with a 9% lower vaccination rate compared to the general population. Individuals with substance use disorder were also 16% less likely to receive the vaccine.
A modelling study suggests that slow waning of MMR vaccine-induced immunity may contribute to rising measles cases in double-vaccinated people. However, the MMR vaccine remains the most effective measure to prevent measles infection, and community vaccination levels above 95% are essential to prevent outbreaks.
Researchers at MIT found that a two-dose schedule for an HIV vaccine can generate a strong response to the virus, outperforming a traditional seven-dose regimen. The first dose primes the immune system, helping it to produce antibodies more effectively when a larger dose is administered one week later.
A new study reveals that two specific genes in the RNA interference pathway play a crucial role in preventing virus transmission from parent to progeny in plants. This discovery could lead to healthier crops and potentially reduce the transmission of diseases like Zika from mothers to human children.
A new study found that RSV vaccination programs targeting older adults with underlying health conditions are more likely to be cost-effective than general age-based strategies. Vaccinating people aged 70 years and older with chronic medical conditions is likely to be cost-effective based on commonly used cost-effectiveness thresholds.
A team of researchers from Osaka University has pinpointed the B cells responsible for boosting COVID-19 immunity after vaccination. They found that activated atypical B cells are the main responders to mRNA vaccines, providing a new way to assess vaccine response and underlying biology.
A new study from Tulane University found that state-level COVID-19 vaccination mandates increased vaccine rates among health care workers by 3-4%, with improvements seen in states that required vaccinations without opt-outs. The policy was particularly effective among health care workers between the ages of 25-49 years.
A new Swedish registry study found that girls with mental illness or neurodevelopmental conditions have lower HPV vaccination coverage compared to their peers. The study involved over 115,000 girls and found significant differences in vaccination rates among those with psychiatric diagnoses or receiving psychotropic medications.
A European study found that prior smallpox vaccination in childhood could offer protection against infections caused by monkeypox virus (MPXV) clade II in men. The estimated degree of protection varied among countries, highlighting the need for further research.
A recent study has confirmed the efficacy and safety of the dengue vaccine TAK-003, which reduces the risk of contracting the disease by over 50%. The vaccine has shown a high safety profile, with more than 90% of adults and children developing antibodies after administration.
A new study by Prof. Eyal Klement and PhD Student Michal Morgenstern has identified key factors influencing vaccination intentions among Israeli dairy farmers, revealing the significant impact of social pressure and underscoring the need for improved communication between veterinarians and farmers.
A new zwitterionic polymer complex has been developed to deliver plasmid DNA into skeletal muscle, achieving widespread gene expression in mice. This breakthrough could lead to new therapies for serious muscular diseases.
Researchers at the University of Chicago have discovered that small molecules can induce trained immunity in innate immune cells, which can fight off seasonal infections and diseases without vaccines. The team found that certain steroids, known to suppress inflammation, can also stimulate a strong immune response.
A study published in JAMA Network Open found no association between RSV vaccination during late pregnancy and increased risk of preterm birth or poor outcomes. The research provides real-world evidence supporting the safety of Pfizer's Abrysvo vaccine, offering reassurance to patients and clinicians.
Researchers at Boston Children's Hospital have discovered a promising vaccine adjuvant called PVP-037, which enhances the immune response to vaccines. The compound, an imidazopyrimidine molecule, targets innate immune cells and stimulates a broader immune response.
Researchers describe a new concept for an immune response against cancer and aging using senescent cell-derived vaccines. The vaccines aim to stimulate the immune system against cancer cells and slow down or reverse aging-related diseases.
Researchers have discovered how a neutralizing antibody blocks measles virus infection by arresting the fusion process. The study's findings may also be relevant to other viruses with pandemic potential, such as Nipah and parainfluenza viruses.
Researchers found that H5N1 virus particles in unpasteurized milk can remain stable on metal and rubber components of commercial milking equipment for over an hour. This increases the potential for bird flu exposure among dairy farm workers and animal-to-animal transmission.
A global meta-analysis of 1.8m women found COVID-19 vaccination reduces the risk of infection during pregnancy by 61% and hospitalization by 94%. Vaccination also lowers caesarean section risk by 9%, hypertensive disorders in pregnancy by 12%, and intensive care unit admission for newborns by 8%.
A new study reveals that 96% of VA hospitals and 74% of non-federal hospitals mandate influenza vaccination or waivers for staff. This surge is largely attributed to the 2020 Veterans Health Administration directive. The increased mandates aim to reduce flu transmission among patients, as health systems strive to improve patient safety.
A new study led by UCSF found that COVID-19 vaccine side effects like headache and tiredness indicate a strong immune response. Those with more symptoms had nearly double the antibody levels of those without, suggesting the vaccine is effective in preventing infection.
A new Yale study published in Obstetrics & Gynecology found no link between COVID-19 vaccination during pregnancy and stillbirth outcomes. The research analyzed hundreds of records from the CDC's Vaccine Safety Datalink, comparing receipt of the vaccine to stillbirths versus live births.
A new study by MIT Sloan researchers found that misleading content from mainstream sources, rather than outright misinformation, was the primary driver of vaccine hesitancy on Facebook. This type of content was seen much more widely and generated more skepticism about COVID-19 vaccines.
A new study by the Colorado School of Public Health found that high ICU occupancy levels during COVID-19 patients' stays contributed to increased mortality rates. The research highlights the critical need for tools to anticipate surges and effective resource management in healthcare systems.
A new review emphasizes the importance of vaccination in preventing avian influenza spread among humans. The study suggests that a diverse range of vaccine platforms, including inactivated and live attenuated vaccines, as well as emerging alternatives like mRNA vaccines, will be crucial for enhancing pandemic preparedness.
A deadly epidemic discovered last year in the Red Sea has spread to the Indian Ocean, annihilating most sea urchin populations and threatening coral reef stability. The researchers identified a scuticociliate parasite as the cause of the mass mortality.
Researchers found that people with a fixed mindset respond better to loss-based messaging framing when discussing vaccination, highlighting the importance of tailored communication strategies. The study generalized its findings to various contagious viruses and has implications for public health messaging.
Researchers at the University of California, Berkeley, have successfully produced the QS-21 adjuvant in yeast, which is currently extracted from tree bark. The production process is cheaper and more environmentally friendly than traditional methods, making it a promising solution for lowering vaccine costs and increasing availability.
Researchers found that SARS-CoV-2 spike protein interrupts p53-MDM2 interaction but does not bind with p53 protein in cancer cells. The study also shows that SARS-CoV-2 spike suppresses p53-dependent gene activation, leading to increased cell viability after chemotherapy exposure.
A survey across 23 countries found that the global population's overall trust in vaccination did not diminish despite COVID-19 pandemic challenges. More than 60% of participants reported increased willingness to get vaccinated for diseases other than COVID-19, suggesting a general openness to vaccination. The study emphasizes the impor...
New research reveals updated vaccines provide a strong immune response against previous strains and emerging variants of COVID-19. Regular vaccinations are recommended for older people or those with underlying medical conditions to combat the virus.
A new study from Wake Forest University School of Medicine found that school-entry requirements are linked to an increase in human papillomavirus (HPV) vaccinations. The study showed that these requirements, currently only implemented in a few states, can lead to higher HPV vaccination rates among adolescents.
A study found a significant increase in negative tweets about vaccines after COVID-19 jabs became available, coinciding with government and healthcare announcements. The researchers argue that a new approach is needed to address negative messaging, avoiding terms like 'anti-vaxxers'.
A York University-led study found that COVID-19 booster shots provide significantly longer-lasting immunity than the primary vaccine series. The researchers used health data from over 150 individuals to model the immune response and controlled for factors like age, sex, and comorbidities.
Researchers at UC Riverside demonstrate a new vaccine strategy targeting a common viral genome part, eliminating the need for annual booster shots. The vaccine uses small RNA molecules to boost the immune system, making it safe for babies and those with weakened immunity.
A new study from the University of Illinois Chicago found that Americans are poor at identifying conspiracy theories when they personally believe in them. Despite this, the study's author argues that recognizing the prevalence of conspiracy theories can help alleviate feelings of isolation and disconnection.
Researchers found that Mpox antibodies decrease significantly within a year of MVA-BN vaccination, especially in individuals without prior smallpox vaccination. In contrast, antibody levels remained high in those with childhood smallpox vaccination, suggesting long-term protection.
Austrian researchers report a breakthrough mpox infection in a fully vaccinated man who received two doses of the Jynneos vaccine. The case highlights the potential durability of protective immunity after complete vaccination and emphasizes the importance of clinical suspicion in high-risk groups.
Low HPV vaccine uptake among US adults aged 27-45 is a concern, particularly for men and Hispanic individuals. Experts stress the need to address disparities in vaccination rates to prevent cancer cases.
Researchers found a 32% vaccine uptake among patients asked about receiving the flu shot and a 41% uptake for those who received a pamphlet, watched a video, and were told about benefits. The study suggests a systematic approach to increase vaccine uptake among underserved populations.
A study found that an annual vaccination campaign with a second dose for children under 2 years old and individuals aged 50 and over can significantly reduce hospitalizations, deaths, and healthcare spending. The optimal timing for the second vaccination is delivering it 5 months after initial vaccination.
A new complex-carbohydrate biomolecule has been identified as crucial for Bordetella bacteria to colonize the nose and transmit to a new host. The discovery opens up possibilities for creating a new drug or vaccine that interferes with this glycan, potentially eliminating whooping cough transmission.
A new study found that COVID-19 vaccine uptake was low across all four UK nations, with only 35% of children receiving the first dose. The study also revealed disparities in vaccination rates based on age, sex, household factors, and location.
Researchers found that adding a note to play up psychological sense of ownership was more effective at convincing people to get the booster. This approach outperformed lab findings and expert insights, highlighting the importance of reproducibility in behavioral science.
Researchers found that initial vaccinations against the ancestral SARS-CoV-2 strain shape immune responses to newer variants BA.5 and XBB, with higher B cell repertoire leading to more effective cross-reactive immunity. This 'immunological imprinting' effect could impact future vaccine designs.
Researchers developed a protein-based vaccine candidate called SpyCage that induces an immune response in rodent models, clearing COVID-19 infections more quickly than controls. The platform has the potential to prevent infection and transmission of respiratory viruses like SARS-CoV-2 by inducing a mucosal immune response.
A landmark study published in JAMA Pediatrics found that COVID vaccines are safe to administer during pregnancy, with no abnormal delays in infants when tested at 12 months and 18 months. The study of over 2,200 infants from across the country also found an increased risk of delay among male infants at 12 months but not at 18 months.
A study found that empathetic communication can significantly improve attitudes towards vaccination and build trust with health professionals. The research, led by the University of Bristol, used a novel dialogue-based technique to address misinformation and misconceptions about vaccines.
A large-scale study published in the BMJ found that children born in October are most likely to be vaccinated and least likely to be diagnosed with influenza, confirming public health guidance of getting flu vaccinations in October. The study analyzed over 800,000 children's health records from 2011-2018.
Researchers identified an optimal approach that uses periods of stricter and less strict lockdowns to accompany recurring epidemic waves. They also found that small changes in key parameters can flip the optimal strategy from one extreme to the other.
A study by UC Davis Health found that a single dose of BCG reduced liver tumor burden and extended the survival of mice with liver cancer. The vaccine boosted the body's immunity, leading to tumor shrinkage and improved liver function.
A new study aims to enhance and prolong vaccine effectiveness by delivering adjuvants to white blood cells using lipid nanoparticles. The research, led by WVU professor Sharan Bobbala, has the potential to provide broader protection against evolving viruses and multiple diseases.
Research finds socioeconomically advantaged parents are less likely to vaccinate their teens against HPV due to safety concerns. Parents from disadvantaged groups cite lack of knowledge as a reason for hesitancy.
A large study of nearly 200,000 newborns in Sweden and Norway found that COVID-19 vaccination during pregnancy was not associated with any increased risks in newborn infants. In fact, babies born to vaccinated mothers had lower mortality rates and fewer serious complications.
Researchers found a four-fold increase in immune response when people alternate arms during two-dose vaccinations. The study showed improved immunity to the original and omicron variants after three weeks and persisted beyond 13 months.
A new study by NYU School of Global Public Health found that Americans who trusted their own doctors were more likely to get vaccinated against COVID-19. In contrast, trust in public officials had no significant impact on vaccination behavior. The researchers conclude that engaging the medical profession in communicating vaccine benefi...